KUNGSBACKA, Sweden--(BUSINESS WIRE)--Regulatory News:
Vitrolife (STO:VITR) has obtained approval in Europe (CE marking) for four new products within the fertility area. The products are used for so-called vitrification, rapid freezing and thawing of cleavage embryos (embryos day 2-3 after fertilization) and of blastocysts (embryos day 5-6 after fertilization).
